Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-05-27 @ 6:48 PM
Study NCT ID:
NCT06178159
Status:
RECRUITING
Last Update Posted:
2025-10-01
First Post:
2023-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
Sponsor:
RemeGen Co., Ltd.
Organization: